Silver Diamine Fluoride is one of 42 small molecule programs targeting Indirect Pulp Cap. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
76 competitors in Effectiveness
Kesimpta
Mounjaro
Actos
Elucirem
Nicotine Free Cigarettes
Lidocain
Botulinum Toxin a
Pneumococcal Conjugate Vaccine
Droxia
Temodar
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details